KORTHOS / ECOSYSTEM / PRODUCT

XoMotion

About

About XoMotion

XoMotion is a self-balancing lower-body exoskeleton platform for people with lower-extremity motor deficits. Its multi-modal controllers and sensor system support hands-free upright movement, allowing rehabilitation teams to train standing and complex walking motions without requiring the user to stabilize continuously through crutches or a walker.

The XoMotion-R configuration is intended for ambulatory training with spinal-cord-injury patients and accommodates users from 5 feet to 6 feet 4 inches tall and up to 220 pounds. Hot-swappable batteries support continuous clinical sessions, while an open-control option exposes kinematic, activity and sensor data to research partners. The company states that XoMotion is not yet FDA cleared, and future therapeutic and personal-mobility variants remain separate development goals.

Capabilities

Source-backed capabilities

  • Assisted walking rehabilitation

    Demonstrated - 2025-02-18 - XoMotion demonstrated at Invictus Games closing ceremony

    Source

Timeline

  • XoMotion wins 2025 TAG MedTech Innovation Award

    2025-05-22 - Award - The Technology Association of Georgia recognized XoMotion in its 2025 MedTech Innovation awards. The award highlighted the exoskeleton as a self-balancing, fully hands-free platform for rehabilitation and mobility support. At the time of the award, XoMotion-R was available to Canadian rehabilitation and research facilities under a Medical Devices Establishment License.

    Source
  • Synaptic Health becomes first XoMotion clinic customer

    2025-02-25 - Contract Award - Synaptic Health became the first rehabilitation center to acquire Human in Motion Robotics XoMotion-R system. The Calgary clinic planned to integrate the exoskeleton into neurorehabilitation for people with spinal-cord injuries and other neurological conditions. The commercial milestone followed Canadian licensing that allowed XoMotion-R to be marketed and sold to rehabilitation and research facilities.

    Source
  • XoMotion demonstrated at Invictus Games closing ceremony

    2025-02-18 - Demonstration - Human in Motion product ambassador Chloë Angus demonstrated XoMotion during the Invictus Games official flag handover. The public demonstration showed the exoskeleton supporting hands-free, self-balancing movement for a user living with paralysis. The company also reported Health Canada clearance for clinical use and availability to Canadian rehabilitation and research facilities.

    Source
  • XoMotion named a CES 2025 Innovation Awards Honoree

    2024-11-21 - Award - The CES Innovation Awards program recognized XoMotion for design and engineering in rehabilitation technology. XoMotion uses 12 actuators to support self-balancing, hands-free and omnidirectional lower-limb movement. The company said the system reduces therapist burden while supporting people with spinal-cord injury, stroke and other neurological impairments.

    Source
  • XoMotion developer closes Series A above $10 million

    2023-05-29 - Funding - The Series A closed at more than $10 million, with Beno Holdings contributing an $8 million strategic investment. The company planned to accelerate research and development, expand production capacity and support market entry. The financing also established a strategic partnership intended to support commercialization and international expansion.

    Source
  • Canada awards Human in Motion $663,000 XoMotion contract

    2022-09-13 - Contract Award - The C$663,000 contract covered two next-generation XoMotion lower-limb exoskeleton units for the Department of National Defence. The units were designated for implementation and evaluation at Queen Elizabeth Hospital in Charlottetown, Prince Edward Island. Human in Motion planned to deliver the first unit by the end of 2022 for testing with volunteer participants.

    Source

Context

Comparable Systems